Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 1/20 | 0.60 |
| ▸ | PPARG | P37231 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.47 |
| ▸ | DRD1 | P21728 | 1/20 | 0.43 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.42 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.38 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxirane SCHEMBL16056663 | 0.91 | STS (0.51) | STSPPARGALDH1A1CYP2A6DRD1 | |
| SCHEMBL576035 | 0.85 | CA2 (0.50) | DRD1CXCR2CXCR1CA1CA2 | |
| SCHEMBL12900893 | 0.85 | STS (0.56) | STSPPARGALDH1A1CYP2A6DRD1 | |
| SCHEMBL5865434 | 0.84 | STS (0.43) | STSPPARGALDH1A1CYP2A6CXCR2 | |
| SCHEMBL7987766 | 0.83 | HPGD (0.49) | STSPPARGALDH1A1CA1CA2 | |
| SCHEMBL943450 | 0.82 | TDP1 (0.42) | STSPPARGALDH1A1DRD1CXCR2 | |
| Hydrogen Sulfide SCHEMBL29027315 | 0.81 | TDP1 (0.41) | STSPPARGALDH1A1DRD1CXCR2 | |
| SCHEMBL16664708 | 0.80 | STS (0.37) | STSPPARGCXCR2CXCR1CA1 | |
| SCHEMBL24080169 | 0.79 | PTGS2 (0.47) | PPARGKDM4ELMNASMN1; SMN2KMT2A | |
| SCHEMBL30440664 | 0.79 | PTGS2 (0.47) | PPARGKDM4ELMNASMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3004120-B1 | SPIRO-1,1'-BIINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALLADIUM-CATALYZED ASYMMETRIC HECK REACTION | UNIV NANYANG TECH (SG) | 2018-08-29 | — | — | EP | claimed |
| US-20160136629-A1 | SPIRO-1,1'-BINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALADIUM-CATALYZED ASYMMETRIC HECK REACTION | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-05-19 | — | — | US | claimed |
| EP-3004120-A1 | SPIRO-1,1'-BIINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALLADIUM-CATALYZED ASYMMETRIC HECK REACTION | Nanyang Technological University (SG) | 2016-04-13 | — | — | EP | claimed |
| WO-2014196930-A1 | SPIRO-1,1'-BIINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALLADIUM-CATALYZED ASYMMETRIC HECK REACTION | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2014-12-11 | — | — | WO | claimed |
| US-10463391-B2 | Magnetic ferrocenyl-functionalized nanoparticle | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2019-11-05 | — | — | US | disclosed |
| US-10370397-B2 | Phosphine substituted ferrocenyl complex | Kind Fahd University of Petroleum and Minerals (SA) | 2019-08-06 | — | — | US | disclosed |
| US-20190029718-A1 | MAGNETIC FERROCENYL-FUNCTIONALIZED NANOPARTICLE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2019-01-31 | — | — | US | disclosed |
| US-20190031697-A1 | PHOSPHINE SUBSTITUTED FERROCENYL COMPLEX | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2019-01-31 | — | — | US | disclosed |
| US-10150110-B2 | Method for making and using a solid-supported catalyst | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-12-11 | — | — | US | disclosed |
| US-10150109-B2 | Palladium(II)-silica supported catalyst | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-12-11 | — | — | US | disclosed |
| US-10150111-B2 | Method for catalytic synthesis of cinnamic acid with catalyst recycle | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-12-11 | — | — | US | disclosed |
| US-20180326410-A1 | METHOD FOR CATALYTIC SYNTHESIS OF CINNAMIC ACID WITH CATALYST RECYCLE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-11-15 | — | — | US | disclosed |
| US-20020143024-A1 | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists | PHARMACOPEIA, LLC | 2002-10-03 | — | — | US | disclosed |
| EP-1237888-A2 | BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS | Bristol-Myers Squibb Company (US) | 2002-09-11 | — | — | EP | disclosed |
| EP-1094816-A4 | BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2001-12-19 | — | — | EP | disclosed |
| CN-1308536-A | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists | BRISTOL MYERS SQUIBB CO (US) | 2001-08-15 | — | — | CN | disclosed |
| WO-2001044239-A2 | BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS | BRISTOL-MYERS SQUIBB CO. (US) | 2001-06-21 | — | — | WO | disclosed |
| EP-1094816-A1 | BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-05-02 | — | — | EP | disclosed |
| WO-2000001389-A1 | BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS | BRISTOL-MYERS SQUIBB CO. (US) | 2000-01-13 | — | — | WO | disclosed |
| US-5464865-A | Enzyme inhibitors as antiinflammatory agents | ORTHO PHARMACEUTICAL CORPORATION (US) | 1995-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10150109-B2 | Palladium(II)-silica supported catalyst | PDK2, SIK2, SIK1 | STS 311/4885PPARG 2566/4885ALDH1A1 1484/4885 |
| US-20160136629-A1 | SPIRO-1,1'-BINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALADIUM-CATALYZED ASYMMETRIC HECK REACTION | SBK1, SIK1, PDPK1 | STS 1047/4885PPARG 1404/4885ALDH1A1 576/4885 |
| US-20180326410-A1 | METHOD FOR CATALYTIC SYNTHESIS OF CINNAMIC ACID WITH CATALYST RECYCLE | DDT, PDK2, CLK2 | STS 464/4885PPARG 3023/4885ALDH1A1 648/4885 |
| US-10370397-B2 | Phosphine substituted ferrocenyl complex | FECH, PHOSPHO1, FTH1 | STS 4308/4885PPARG 3562/4885ALDH1A1 4562/4885 |
| US-20020143024-A1 | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists | EDNRB, AGTR2, EDNRA | STS 65/4885PPARG 655/4885ALDH1A1 1854/4885 |
| US-20190031697-A1 | PHOSPHINE SUBSTITUTED FERROCENYL COMPLEX | FECH, FOLR1, FOLR2 | STS 4127/4885PPARG 2121/4885ALDH1A1 3450/4885 |
| US-10150111-B2 | Method for catalytic synthesis of cinnamic acid with catalyst recycle | DDT, PDK2, CLK2 | STS 464/4885PPARG 3023/4885ALDH1A1 648/4885 |
| US-10150110-B2 | Method for making and using a solid-supported catalyst | AOC1, SOD1, PDK2 | STS 316/4885PPARG 2579/4885ALDH1A1 891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.